更新日期 | 產(chǎn)品編號(hào) | 品牌 | 產(chǎn)品信息 | CAS號(hào) | MDL號(hào) | 規(guī)格與純度 | 包裝 | 價(jià)格 | 庫(kù)存信息 | 操作 |
2024/11/08
|
HY-50686
|
|
(3R,4R)-3-(5,6-二氫-4H-吡咯并[3,2,1-IJ]喹啉-1-基)-4-(1H-吲哚-3-基)吡咯烷-2,5-二酮 Tivantinib
|
905854-02-6
|
|
|
5mg
|
558元
|
In-stock
|
詳細(xì)
|
2024/11/08
|
HY-50686
|
|
(3R,4R)-3-(5,6-二氫-4H-吡咯并[3,2,1-IJ]喹啉-1-基)-4-(1H-吲哚-3-基)吡咯烷-2,5-二酮 Tivantinib
|
905854-02-6
|
|
|
10mM * 1mLin DMSO
|
614元
|
In-stock
|
詳細(xì)
|
2024/11/08
|
HY-50686
|
|
(3R,4R)-3-(5,6-二氫-4H-吡咯并[3,2,1-IJ]喹啉-1-基)-4-(1H-吲哚-3-基)吡咯烷-2,5-二酮 Tivantinib
|
905854-02-6
|
|
|
10mg
|
837元
|
In-stock
|
詳細(xì)
|
2024/11/08
|
HY-50686
|
|
(3R,4R)-3-(5,6-二氫-4H-吡咯并[3,2,1-IJ]喹啉-1-基)-4-(1H-吲哚-3-基)吡咯烷-2,5-二酮 Tivantinib
|
905854-02-6
|
|
|
50mg
|
2800元
|
In-stock
|
詳細(xì)
|
2024/11/08
|
HY-50686
|
|
(3R,4R)-3-(5,6-二氫-4H-吡咯并[3,2,1-IJ]喹啉-1-基)-4-(1H-吲哚-3-基)吡咯烷-2,5-二酮 Tivantinib
|
905854-02-6
|
|
|
100mg
|
3800元
|
In-stock
|
詳細(xì)
|
2024/11/08
|
S2753
|
|
(3R,4R)-3-(5,6-二氫-4H-吡咯并[3,2,1-IJ]喹啉-1-基)-4-(1H-吲哚-3-基)吡咯烷-2,5-二酮 Tivantinib (ARQ 197)
|
905854-02-6
|
|
|
10mg
|
904.93元
|
現(xiàn)貨
|
詳細(xì)
|
2024/11/08
|
S2753
|
|
Tivantinib (ARQ 197)
|
905854-02-6
|
|
|
10mM (1mL in DMSO)
|
958.23元
|
現(xiàn)貨
|
詳細(xì)
|
2024/11/08
|
S2753
|
|
(3R,4R)-3-(5,6-二氫-4H-吡咯并[3,2,1-IJ]喹啉-1-基)-4-(1H-吲哚-3-基)吡咯烷-2,5-二酮 Tivantinib (ARQ 197)
|
905854-02-6
|
|
|
50mg
|
3844.69元
|
現(xiàn)貨
|
詳細(xì)
|
2024/08/19
|
HY-50686
|
|
(3R,4R)-3-(5,6-二氫-4H-吡咯并[3,2,1-IJ]喹啉-1-基)-4-(1H-吲哚-3-基)吡咯烷-2,5-二酮 Tivantinib
|
905854-02-6
|
|
|
200mg
|
6800元
|
In-stock
|
詳細(xì)
|
2023/10/26
|
HY-50686
|
|
(3R,4R)-3-(5,6-二氫-4H-吡咯并[3,2,1-IJ]喹啉-1-基)-4-(1H-吲哚-3-基)吡咯烷-2,5-二酮 Tivantinib
|
905854-02-6
|
|
|
500mg
|
13500元
|
In-stock
|
詳細(xì)
|